MDPI and ACS Style
Rosenzweig, B.; Haramaty, R.; Davidson, T.; Lazarovich, A.; Shvero, A.; Haifler, M.; Gal, J.; Golan, S.; Shpitzer, S.; Hoffman, A.;
et al. Reply to Veerman et al. Comment on “Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410”. J. Pers. Med. 2022, 12, 861.
https://doi.org/10.3390/jpm12060861
AMA Style
Rosenzweig B, Haramaty R, Davidson T, Lazarovich A, Shvero A, Haifler M, Gal J, Golan S, Shpitzer S, Hoffman A,
et al. Reply to Veerman et al. Comment on “Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410”. Journal of Personalized Medicine. 2022; 12(6):861.
https://doi.org/10.3390/jpm12060861
Chicago/Turabian Style
Rosenzweig, Barak, Rennen Haramaty, Tima Davidson, Alon Lazarovich, Asaf Shvero, Miki Haifler, Jonathan Gal, Shay Golan, Sagi Shpitzer, Azik Hoffman,
and et al. 2022. "Reply to Veerman et al. Comment on “Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410”" Journal of Personalized Medicine 12, no. 6: 861.
https://doi.org/10.3390/jpm12060861
